021-51111890
购物车（）
sales@molnova.cn
DAGLβ-IN-1
CAS No. 1402612-61-6
DAGLβ-IN-1 ( —— )
产品货号. M26143 CAS No. 1402612-61-6
DAGLβ-IN-1 是一种通用中间体，用于设计 DAGL 定制的基于活性的探针，并且是二酰基甘油脂肪酶-β (DAGLβ) 的抑制剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥2373 | 有现货 |
|
| 5MG | ￥3621 | 有现货 |
|
| 10MG | ￥5338 | 有现货 |
|
| 25MG | ￥7995 | 有现货 |
|
| 50MG | ￥11178 | 有现货 |
|
| 100MG | ￥15309 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称DAGLβ-IN-1
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述DAGLβ-IN-1 是一种通用中间体，用于设计 DAGL 定制的基于活性的探针，并且是二酰基甘油脂肪酶-β (DAGLβ) 的抑制剂。
-
产品描述DAGLβ-IN-1 is a universal intermediate for designing DAGL tailored activity-based probes, and is an inhibitor of diacylglycerol lipase-β (DAGLβ).(In Vitro):Diacylglycerol lipase-β (DAGLβ) is the main biosynthetic enzyme of endogenous cannabinoid 2-arachidonic acid glycerol (2-AG).
-
体外实验Diacylglycerol lipase-β (DAGLβ) is a principal biosynthetic enzyme for the endocannabinoid 2-arachidonoylglycerol (2-AG).
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number1402612-61-6
-
分子量561.606
-
分子式C28H34F3N5O4
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCC(C)(C)OC(=O)NCCCCCN(CCc1ccccc1)C(=O)n1cc(nn1)-c1ccc(OC(F)(F)F)cc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
-
Ziconotide TFA (1074...
Ziconotide TEA acts by binding to N-type calcium channels situated on the terminal part of primary afferent neurons of the nociceptive pathway therefore reducing synaptic transmission with potent antinociceptive effects.
-
Helodermin
Helodormin is a VIP-secretin-like peptide isolated from the venom of the Mexican monster lizard (Heloderma suspectum). Helodormin affects a variety of cellular functions by modulating intracellular signaling through activation of adenylate cyclase. Helodormin can be used to study the evolution and function of the secretin and VIP peptide families.
-
4-O-Methylhonokiol
4-O-Methyl honokiol, a natural neolignan isolated from Magnolia officinalis, acts as a PPARγ agonist and inhibits NF-κB activity, used for cancer and inflammation research.
